Fatty Liver - Pearland TX

Summary:

We are doing this study to see if the medicine called semaglutide can help patients with NASH get better and reduce their risk of future liver complications. NASH is a disease where fat, inflammation and scar tissue build up in the liver. Semaglutide may improve these liver damages. By improving liver damage it might be possible to prevent future liver complications. Semaglutide is already used by doctors to treat patients with type 2 diabetes in many countries. It is also used in research studies of patients with obesity and of patients with different stages of NASH. 

Also, the information we collect can help us better understand:

- NASH or related diseases

- how the study medicine works in the body

- how w to improve the treatment of people with NASH or related diseases

Qualified Participants Must:

• Age above or equal to 18 years at the time of signing informed consent
• Histological evidence of NASH based on a central pathologist evaluation of the baseline liver biopsy
• The baseline liver biopsy can be a historical biopsy obtained within 180 days prior to the screening visit (V1)
• Histological evidence of fibrosis stage 2 or stage 3 according to the NASH CRN classification based on a central pathologist evaluation of the baseline liver biopsy
• A histological NAS 4 or greater with a score of 1 or more in steatosis, lobular inflammation and hepatocyte ballooning based on a central pathologist evaluation of the baseline liver biopsy

Qualified Participants May Receive:

1) $100.00 for each completed scheduled visit where a biopsy or fibroscan is not performed.

2) $180.00 per visit where biopsy is performed.

3) $80.00 per visit where fibroscan is performed.